Crossref
Development of Intranasal Powder Formulations for Brain-Targeted Delivery of Peptide Drugs
Hosokawa Powder Technology Foundation ANNUAL REPORT · 26.05.2026 · 33 · 66-69
DOI: 10.14356/hptf.23109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hosokawa Powder Technology Foundation ANNUAL REPORT, erschienen am 26.05.2026. Verfasst von Akiko TANAKA. Die Arbeit nennt 5 Literaturangaben. Gefördert von: Hosokawa Powder Technology Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Hosokawa Powder Technology Foundation
Zitieren
APA
TANAKA, A. (2026). Development of Intranasal Powder Formulations for Brain-Targeted Delivery of Peptide Drugs. Hosokawa Powder Technology Foundation ANNUAL REPORT, 33(0), 66-69. https://doi.org/10.14356/hptf.23109
Vancouver
TANAKA A. Development of Intranasal Powder Formulations for Brain-Targeted Delivery of Peptide Drugs. Hosokawa Powder Technology Foundation ANNUAL REPORT. 2026;33(0):66-69. doi:10.14356/hptf.23109
BibTeX
@article{TANAKA2026,
author = {TANAKA, Akiko},
title = {Development of Intranasal Powder Formulations for Brain-Targeted Delivery of Peptide Drugs},
journal = {Hosokawa Powder Technology Foundation ANNUAL REPORT},
year = {2026},
volume = {33},
number = {0},
pages = {66--69},
doi = {10.14356/hptf.23109}
}
EUVIMED